Valuation check: TECH's profit margin is 14.97%, above the Healthcare sector average of 14.41%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), TECH shows a profit margin of 14.97%. That compares with 6.02% in the prior-year period — up 148.7% year over year. That is above the Healthcare sector average of 14.41%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TECH's profit margin is now 14.97% (was 6.02%) — a 148.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Techne is outperforming or lagging.
The Healthcare sector average profit margin is about 14.41%. Bio-Techne is at 14.97%, which is higher that average. That is roughly 3.8% above the sector mean. Use the comparison chart on this page to see how TECH stacks up against individual peers as well.
That compares with 6.02% in the prior-year period — up 148.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Bio-Techne with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Bio-Techne's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 14.97%) with ownership activity and broader fundamentals.